METX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
ME Therapeutics Holdings, Inc. provides biotechnology and pharmaceutical services. It engages in research and development of cancer fighting drugs in the field of immuno-oncology (IO). ME Therapeutics Holdings develops drug candidates that can increase the efficacy of current IO drugs by targeting suppressive myeloid cells which are known to hinder the effectiveness of current IO treatments. The company was founded on November 9, 2021 and is headquartered in Vancouver, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
METX does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company